Revolution Medicines, Inc. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -41.79M-47.66M-108.16M-187.09M-248.71M-436.37M-600.05M
Depreciation and Depletion 3.08M4.00M5.00M6.20M
Share-based Compensation 0.85M3.16M8.89M20.72M31.20M61.77M79.20M
Deferred Taxes 4.37M0.38M0.42M3.91M0.76M
Gains from Sales and Divestitures 0.00M0.08M0.28M0.58M1.01M
Gains from Investment Securities 0.40M0.40M21.70M35.44M3.80M25.27M44.58M
Non-cash Items 5.08M51.28M165.09M83.95M85.18M115.01M118.80M
Cash from Operations 1.21M-49.62M-100.06M-147.18M-224.40M-350.57M-557.44M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.20M1.10M2.87M3.18M4.62M22.20M44.56M
Amortization of Deferred Charges 2.87M3.18M
Depreciation & Amortization (CF) 1.57M2.27M2.61M3.10M3.97M5.04M6.56M
Change in Working Capital
Change in Receivables 7.30M1.43M-2.34M-0.46M-1.26M-3.42M-1.25M
Change in Account Payables 0.11M5.26M0.30M2.24M7.29M32.47M-6.46M
Change in Accured Expenses 1.91M6.04M4.86M8.72M1.50M14.67M21.98M
Other Working Capital Changes 0.91M-13.39M-11.26M-1.66M-14.47M-4.46M9.70M
Investing Activities
Capital Expenditures 1.50M2.59M2.93M6.53M10.82M7.73M10.31M
Sales of Property, Plant and Equipment 0.20M
Acquisitions 0.16M
Cash from Investing Activities -1.34M-101.97M-234.23M-142.12M-24.12M-342.60M-554.39M
Financing Activities
Cash from Financing Activities 60.85M98.66M422.78M294.18M301.43M1229.20M959.41M
Additional items
Change in Cash 60.72M-52.93M88.48M4.88M52.91M536.03M-152.42M
Free Cash Flow -0.29M-52.20M-103.00M-153.71M-235.22M-358.30M-567.74M
Net Cash Flow 60.72M-52.93M88.48M4.88M52.91M536.03M-152.42M